Gz. Han et al., ANTIPLATELET EFFECTS OF R,S-(MESO)-ALPHA, '-BIS[3-(N,N-DIETHYLCARBAMOYL)PIPERIDINO]-P-XYLENE EX-VIVO IN THE DOG AND IN-VIVO IN THE MOUSE, General pharmacology, 28(4), 1997, pp. 617-621
1. The nipecotamide '-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene
(A-1) is a platelet aggregation inhibitor. The meso diastereomer A-1c
is superior in potency and duration to the synthetic diastereomeric m
ixture consisting of the R,R-, S,S-, and R,S- (meso) isomers in inhibi
ting collagen-induced platelet aggregation ex vivo in the dog. 2. A-1c
also is more potent and longer acting than A-1 in protecting mice fro
m collagen+epinephrine-induced thromboembolic death. 3. The mechanism
of antiplatelet action of this compound appears to be related to its a
bility to prevent agonist-induced inhibition of platelet cyclic adenos
ine monophosphate (cAMP) levels. (C) 1997 Elsevier Science Inc.